Cargando…
Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model
Anthrax is primarily recognized as an affliction of herbivores with incubation period ranging from three to five days post-infection. Currently, the Sterne live-spore vaccine is the only vaccine approved for control of the disease in susceptible animals. While largely effective, the Sterne vaccine h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240085/ https://www.ncbi.nlm.nih.gov/pubmed/30446695 http://dx.doi.org/10.1038/s41598-018-35382-8 |
_version_ | 1783371569511268352 |
---|---|
author | Ndumnego, Okechukwu C. Koehler, Susanne M. Crafford, Jannie E. Beyer, Wolfgang van Heerden, Henriette |
author_facet | Ndumnego, Okechukwu C. Koehler, Susanne M. Crafford, Jannie E. Beyer, Wolfgang van Heerden, Henriette |
author_sort | Ndumnego, Okechukwu C. |
collection | PubMed |
description | Anthrax is primarily recognized as an affliction of herbivores with incubation period ranging from three to five days post-infection. Currently, the Sterne live-spore vaccine is the only vaccine approved for control of the disease in susceptible animals. While largely effective, the Sterne vaccine has several problems including adverse reactions in sensitive species, ineffectiveness in active outbreaks and incompatibility with antibiotics. These can be surmounted with the advent of recombinant peptides (non-living) next generation vaccines. The candidate vaccine antigens comprised of recombinant protective antigen (PA), spore-specific antigen (bacillus collagen-like protein of anthracis, BclA) and formaldehyde inactivated spores (FIS). Presently, little information exists on the protectivity of these novel vaccine candidates in susceptible ruminants. Thus, this study sought to assess the immunogenicity of these vaccine candidates in goats and evaluate their protectivity using an in vivo mouse model. Goats receiving a combination of PA, BclA and FIS yielded the highest antibody and toxin neutralizing titres compared to recombinant peptides alone. This was also reflected in the passive immunization experiment whereby mice receiving immune sera from goats vaccinated with the antigen combination had higher survival post-challenge. In conclusion, the current data indicate promising potential for further development of non-living anthrax vaccines in ruminants. |
format | Online Article Text |
id | pubmed-6240085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62400852018-11-26 Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model Ndumnego, Okechukwu C. Koehler, Susanne M. Crafford, Jannie E. Beyer, Wolfgang van Heerden, Henriette Sci Rep Article Anthrax is primarily recognized as an affliction of herbivores with incubation period ranging from three to five days post-infection. Currently, the Sterne live-spore vaccine is the only vaccine approved for control of the disease in susceptible animals. While largely effective, the Sterne vaccine has several problems including adverse reactions in sensitive species, ineffectiveness in active outbreaks and incompatibility with antibiotics. These can be surmounted with the advent of recombinant peptides (non-living) next generation vaccines. The candidate vaccine antigens comprised of recombinant protective antigen (PA), spore-specific antigen (bacillus collagen-like protein of anthracis, BclA) and formaldehyde inactivated spores (FIS). Presently, little information exists on the protectivity of these novel vaccine candidates in susceptible ruminants. Thus, this study sought to assess the immunogenicity of these vaccine candidates in goats and evaluate their protectivity using an in vivo mouse model. Goats receiving a combination of PA, BclA and FIS yielded the highest antibody and toxin neutralizing titres compared to recombinant peptides alone. This was also reflected in the passive immunization experiment whereby mice receiving immune sera from goats vaccinated with the antigen combination had higher survival post-challenge. In conclusion, the current data indicate promising potential for further development of non-living anthrax vaccines in ruminants. Nature Publishing Group UK 2018-11-16 /pmc/articles/PMC6240085/ /pubmed/30446695 http://dx.doi.org/10.1038/s41598-018-35382-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ndumnego, Okechukwu C. Koehler, Susanne M. Crafford, Jannie E. Beyer, Wolfgang van Heerden, Henriette Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title | Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title_full | Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title_fullStr | Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title_full_unstemmed | Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title_short | Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model |
title_sort | immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in a/j mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240085/ https://www.ncbi.nlm.nih.gov/pubmed/30446695 http://dx.doi.org/10.1038/s41598-018-35382-8 |
work_keys_str_mv | AT ndumnegookechukwuc immunogenicityofanthraxrecombinantpeptidesandkilledsporesingoatsandprotectiveefficacyofimmuneserainajmousemodel AT koehlersusannem immunogenicityofanthraxrecombinantpeptidesandkilledsporesingoatsandprotectiveefficacyofimmuneserainajmousemodel AT craffordjanniee immunogenicityofanthraxrecombinantpeptidesandkilledsporesingoatsandprotectiveefficacyofimmuneserainajmousemodel AT beyerwolfgang immunogenicityofanthraxrecombinantpeptidesandkilledsporesingoatsandprotectiveefficacyofimmuneserainajmousemodel AT vanheerdenhenriette immunogenicityofanthraxrecombinantpeptidesandkilledsporesingoatsandprotectiveefficacyofimmuneserainajmousemodel |